documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

6 rows where docket_id = "FDA-2006-E-0129" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date (date), comment_start_date (date), last_modified (date)

document_type 3

posted_year 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-E-0129-0006 FDA Patent Extension Application for CYMBALTA (duloxetine hydrochloride), U.S. Patent No. 5,023,269 FDA-2006-E-0129 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Eli Lilly and Company Rule Certificate Extending Patent Term 2007-05-07T04:00:00Z 2007 5     2025-12-10T10:00:06Z   0 0 0900006480450277
FDA-2006-E-0129-0005 FDA Patent Extension Application for CYMBALTA (duloxetine hydrochloride), U.S. Patent No. 5,023,269 FDA-2006-E-0129 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2007-03-12T05:00:00Z 2007 3     2025-12-10T02:01:21Z   0 0 0900006480450276
FDA-2006-E-0129-0004 FDA Patent Extension Application for CYMBALTA (duloxetine hydrochloride), U.S. Patent No. 5,023,269 FDA-2006-E-0129 Determination of Regulatory Review Period for Purposes of Patent Extension; CYMBALTA Notice General Notice 2006-08-03T04:00:00Z 2006 8 2006-08-03T04:00:00Z   2025-12-10T01:59:40Z E6-12574 0 0 0900006480450273
FDA-2006-E-0129-0003 FDA Patent Extension Application for CYMBALTA (duloxetine hydrochloride), U.S. Patent No. 5,023,269 FDA-2006-E-0129 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2006-06-21T04:00:00Z 2006 6     2025-12-10T01:56:01Z   0 0 0900006480450272
FDA-2006-E-0129-0002 FDA Patent Extension Application for CYMBALTA (duloxetine hydrochloride), U.S. Patent No. 5,023,269 FDA-2006-E-0129 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2006-02-28T05:00:00Z 2006 2     2025-12-10T01:54:17Z   0 0 090000648045026c
FDA-2006-E-0129-0001 FDA Patent Extension Application for CYMBALTA (duloxetine hydrochloride), U.S. Patent No. 5,023,269 FDA-2006-E-0129 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2006-01-05T05:00:00Z 2006 1     2025-12-10T01:52:21Z   0 0 0900006480450262

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);